C. Degirolamo

发表

Biliary sterol secretion is not required for macrophage reverse cholesterol transport.

J. M. Brown, J. Sawyer, L. Rudel, 2010, Cell metabolism.

Bile acids and colon cancer: Solving the puzzle with nuclear receptors.

A. Moschetta, C. Degirolamo, S. Modica, 2011, Trends in molecular medicine.

Redesigning the path of care and treatment goals in patients with chronic pain: ideas from the Science of Relief 2.0 event

G. Varrassi, C. Degirolamo, M. R. Natale, 2021, Drugs in Context.

Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.

A. Moschetta, C. Degirolamo, S. Murzilli, 2014, Cell reports.

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

A. Moschetta, C. Degirolamo, C. Sabbà, 2015, Nature Reviews Drug Discovery.

Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver

C. Cicione, A. Moschetta, C. Degirolamo, 2012, Hepatology.

Dietary n-3 LCPUFA from fish oil but not α-linolenic acid-derived LCPUFA confers atheroprotection in mice[S]

L. Rudel, C. Degirolamo, Martha D. Wilson, 2010, Journal of Lipid Research.

Casting a shadow on liver X receptor‐mediated atheroprotection: is LXRβ to blame?

A. Moschetta, C. Degirolamo, 2012, Journal of internal medicine.

Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice

M. Eriksson, J. Gustafsson, M. Graham, 2014, PloS one.

Targeted Deletion of Hepatocyte ABCA1 Leads to Very Low Density Lipoprotein Triglyceride Overproduction and Low Density Lipoprotein Hypercatabolism*

M. Hayden, N. Maeda, Soonkyu Chung, 2010, The Journal of Biological Chemistry.

Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor–null mice by intestinal‐specific farnesoid X receptor reactivation

M. Vacca, A. Moschetta, C. Degirolamo, 2015, Hepatology.

Pyripyropene A, an Acyl–Coenzyme A: Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia

Hiroshi Tomoda, Satoshi Omura, S. Ōmura, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome

M. Vacca, R. Mariani-Costantini, A. Moschetta, 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

Dietary Monounsaturated Fatty Acids Appear Not to Provide Cardioprotection

L. Rudel, C. Degirolamo, Chiara Degirolamo, 2010, Current atherosclerosis reports.

Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of Fxr/Fgf15 axis in mice” Authors:

A. Moschetta, C. Degirolamo, S. Murzilli, 2014 .

Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis

Heather M. Alger, J. M. Brown, Soonkyu Chung, 2008, Circulation.

Combined Therapy of Dietary Fish Oil and Stearoyl-CoA Desaturase 1 Inhibition Prevents the Metabolic Syndrome and Atherosclerosis

J. Madenspacher, M. Fessler, Heather M. Alger, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Intestinal nuclear receptors in HDL cholesterol metabolism

A. Moschetta, C. Degirolamo, C. Sabbà, 2015, Journal of Lipid Research.

Nuclear receptors in regenerating liver and hepatocellular carcinoma

M. Vacca, R. Mariani-Costantini, A. Moschetta, 2013, Molecular and Cellular Endocrinology.

Inhibition of Stearoyl-CoA Desaturase 1 (SCD1) DissociatesInsulin Resistance and Obesity From Atherosclerosis

Heather M. Alger, J. M. Brown, Soonkyu Chung, 2016 .